Kangmei Pharma | 600518 - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Akebia Therapeutics USD 47.28M 1.7M 2025-12
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
Avita Medical AUD 14.31M 639K 2025-12
Cspc Pharmaceutical CNY 4.01B 329.18M 2025-12
Dianthus Therapeutics USD 463K 179K 2026-03
Genomma Lab Internacional MXN 2.66B 208.35M 2026-03
Hypermarcas BRL 1.21B 167.56M 2026-03
Ionis Pharmaceuticals USD 243M 48M 2026-03
IQVIA Holdings USD 1.07B 52M 2026-03
Jiangsu Hengrui CNY 7.27B 918.27M 2025-12
Kangmei Pharma CNY 238.34M 31.95M 2026-03
Moderna USD -566M 792M 2026-03
Organon & Co USD 783M 71M 2026-03
Revvity USD 387.66M 34M 2026-03
Sh Fosun Pharma CNY 6.69B 1.9B 2025-12
Tectonic Therapeutic USD 0 0 2025-03
Viatris USD 1.38B 229.9M 2026-03
Wuxi Apptec CNY 6.27B 68.16M 2026-03
Xeris Pharmaceuticals USD 72.55M 404K 2026-03
Zz Pientze Pharmaceu CNY 1.16B 860.2M 2026-03